• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：基于深度学习的非小细胞肺癌脑转移中表皮生长因子受体和间变性淋巴瘤激酶状态的自动预测

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.

作者信息

Mahajan Abhishek, B Gurukrishna, Wadhwa Shweta, Agarwal Ujjwal, Baid Ujjwal, Talbar Sanjay, Janu Amit Kumar, Patil Vijay, Noronha Vanita, Mummudi Naveen, Tibdewal Anil, Agarwal J P, Yadav Subhash, Kaushal Rajiv Kumar, Puranik Ameya, Purandare Nilendu, Prabhash Kumar

机构信息

Clatterbridge Centre for Oncology NHS Foundation Trust, L7 8YA Liverpool, UK.

Department of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.

出版信息

Explor Target Antitumor Ther. 2024;5(4):800. doi: 10.37349/etat.2024.00248. Epub 2024 Jul 8.

DOI:10.37349/etat.2024.00248
PMID:39280247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11390288/
Abstract

[This corrects the article DOI: 10.37349/etat.2023.00158.].

摘要

[本文更正了文章的数字对象标识符：10.37349/etat.2023.00158。]

相似文献

1
Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.更正：基于深度学习的非小细胞肺癌脑转移中表皮生长因子受体和间变性淋巴瘤激酶状态的自动预测
Explor Target Antitumor Ther. 2024;5(4):800. doi: 10.37349/etat.2024.00248. Epub 2024 Jul 8.
2
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.一名对克唑替尼产生获得性耐药的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变：病例报告
BMC Res Notes. 2013 Nov 26;6:489. doi: 10.1186/1756-0500-6-489.
3
A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.一项针对既往接受过治疗、无表皮生长因子受体突变和间变性淋巴瘤激酶重排的非小细胞肺癌患者的每周一次纳米白蛋白结合型紫杉醇I/II期试验。
Asia Pac J Clin Oncol. 2019 Aug;15(4):250-256. doi: 10.1111/ajco.13147. Epub 2019 Apr 1.
4
Regional reporting of the incidence of Anaplastic Lymphoma Kinase mutation in 379 non-small-cell lung cancer patients from Kolkata: Using immunohistochemistry as the diagnostic modality in a significant subset.加尔各答379例非小细胞肺癌患者间变性淋巴瘤激酶突变发生率的区域报告：在相当一部分患者中使用免疫组织化学作为诊断方法
South Asian J Cancer. 2017 Oct-Dec;6(4):169-170. doi: 10.4103/sajc.sajc_65_17.
5
First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis: A case report and review of the literature.一线培美曲塞、卡铂联合安罗替尼治疗表皮生长因子受体野生型和间变性淋巴瘤激酶阴性且伴有脑转移的肺腺癌：一例报告并文献复习
Medicine (Baltimore). 2020 Sep 4;99(36):e22128. doi: 10.1097/MD.0000000000022128.
6
Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.瑞士晚期非小细胞肺癌患者的表皮生长因子受体和间变性淋巴瘤激酶检测及突变发生率：对实际临床实践的综合评估
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12721. Epub 2017 May 30.
7
Concomitant echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in non-small cell lung cancer patients from eastern India.印度东部非小细胞肺癌患者中棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶重排与表皮生长因子受体突变共存
J Cancer Res Ther. 2020 Jul-Sep;16(4):850-854. doi: 10.4103/jcrt.JCRT_678_18.
8
Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer.在台湾非小细胞肺癌中，间变性淋巴瘤激酶易位与间变性淋巴瘤激酶表达相关，且与表皮生长因子受体突变相互排斥。
Pathol Int. 2015 May;65(5):231-9. doi: 10.1111/pin.12268. Epub 2015 Feb 23.
9
Efficacy and safety of first-line treatments for patients with advanced anaplastic lymphoma kinase mutated, non-small cell cancer: A systematic review and network meta-analysis.一线治疗晚期间变性淋巴瘤激酶突变型非小细胞肺癌患者的疗效和安全性：系统评价和网络荟萃分析。
Cancer. 2023 Apr 15;129(8):1261-1275. doi: 10.1002/cncr.34664. Epub 2023 Feb 7.
10
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients.结合CT图像和临床病理信息的深度学习模型，用于预测非小细胞肺癌患者的ALK融合状态及对ALK-TKI治疗的反应。
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):361-371. doi: 10.1007/s00259-020-04986-6. Epub 2020 Aug 13.

引用本文的文献

1
The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status.认知衰退中的肥胖悖论：体重指数动态变化和载脂蛋白E基因型对不同认知状态的影响
Diabetes Obes Metab. 2025 Jul;27(7):3967-3983. doi: 10.1111/dom.16433. Epub 2025 May 2.